Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3066)
All Articles published online
|
Mar 7, 2008 (publication date) through Aug 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jang HS, Kang KM, Choi BO, Chai GY, Hong SC, Ha WS, Jirtle RL. Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma. World J Gastroenterol 2008; 14(9): 1394-1398 [PMID: 18322954 DOI: 10.3748/wjg.14.1394] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i9/1394.htm |
| Number | Citing Articles |
| 1 |
Y. Wang, R.G. MacDonald, G. Thinakaran, S. Kar. Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases. Molecular Neurobiology 2017; 54(4): 2636 doi: 10.1007/s12035-016-9849-7
|
| 2 |
Chia-Jui Weng, Yi-Hsien Hsieh, Chiung-Man Tsai, Yin-Hung Chu, Kwo-Chang Ueng, Yu-Fan Liu, Yuan-Hung Yeh, Shih-Chi Su, Yi-Chen Chen, Mu-Kuan Chen, Shun-Fa Yang. Relationship of Insulin-Like Growth Factors System Gene Polymorphisms with the Susceptibility and Pathological Development of Hepatocellular Carcinoma. Annals of Surgical Oncology 2010; 17(7): 1808 doi: 10.1245/s10434-009-0904-8
|
| 3 |
Jai Prakash, Leonie Beljaars, Akshay K. Harapanahalli, Mieke Zeinstra‐Smith, Alie de Jager‐Krikken, Martin Hessing, Herman Steen, Klaas Poelstra. Tumor‐targeted intracellular delivery of anticancer drugs through the mannose‐6‐phosphate/insulin‐like growth factor II receptor. International Journal of Cancer 2010; 126(8): 1966 doi: 10.1002/ijc.24914
|
| 4 |
James Brown, E. Yvonne Jones, Briony E. Forbes. Keeping IGF-II under control: Lessons from the IGF-II–IGF2R crystal structure. Trends in Biochemical Sciences 2009; 34(12): 612 doi: 10.1016/j.tibs.2009.07.003
|
| 5 |
Lin Zhou, Wuhua Zhou, Liming Wu, Xiaobo Yu, Chunyang Xing, Shusen Zheng. The association of frequent allelic loss on 17p13.1 with early metastastic recurrence of hepatocellular carcinoma after liver transplantation. Journal of Surgical Oncology 2010; 102(7): 802 doi: 10.1002/jso.21743
|
| 6 |
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda, Osama Hegazy. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 2014; 68(1): 50 doi: 10.1016/j.cyto.2014.02.006
|
| 7 |
Irena Martin-Kleiner, Koraljka Gall Troselj. Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis. Cancer Letters 2010; 289(1): 11 doi: 10.1016/j.canlet.2009.06.036
|
| 8 |
Katsuhiro Ogawa. Molecular pathology of early stage chemically induced hepatocarcinogenesis. Pathology International 2009; 59(9): 605 doi: 10.1111/j.1440-1827.2009.02416.x
|
| 9 |
Xisheng Wang, Nairag Asgenbaatar, Yingchao Shen, Minna Yi, Bilig Zhao, Hong Ren, Toli Davshilt, Tseweendolmaa Ulaangerel, Min Wang, Als Burenbaatar, Shuyue Tian, Bei Li, Manglai Dugarjav, Gerelchimeg Bou. Lower expression of the equine maternally imprinted gene IGF2R is related to the slow proliferation of hinny embryonic fibroblast in vitro. Molecular Biology Reports 2023; 50(1): 185 doi: 10.1007/s11033-022-07937-6
|
| 10 |
J. Brown, E.Y. Jones, B.E. Forbes. Insulin and IGFs. Vitamins & Hormones 2009; 80: 699 doi: 10.1016/S0083-6729(08)00625-0
|
| 11 |
Yeonhwa Song, Jin-Sun Kim, Se-Hyuk Kim, Yoon Kyung Park, Eunsil Yu, Ki-Hun Kim, Eul-Ju Seo, Heung-Bum Oh, Han Chu Lee, Kang Mo Kim, Haeng Ran Seo. Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0752-0
|
| 12 |
Zhao-Shan Niu, Xiao-Jun Niu, Wen-Hong Wang. Genetic alterations in hepatocellular carcinoma: An update. World Journal of Gastroenterology 2016; 22(41): 9069-9095 doi: 10.3748/wjg.v22.i41.9069
|
| 13 |
L.S.S. Srivani Nagam, Ramakrishna Vadde, Rajeswari Jinka. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 125 doi: 10.1016/B978-0-323-98806-3.00013-1
|
| 14 |
Mariam Ahmed Galal, Samhar Samer Alouch, Buthainah Saad Alsultan, Huda Dahman, Nouf Abdullah Alyabis, Sarah Ammar Alammar, Ahmad Aljada. Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. International Journal of Molecular Sciences 2023; 24(19): 15006 doi: 10.3390/ijms241915006
|
| 15 |
Melchiorre Cervello, Giuseppa Augello, Antonella Cusimano, Maria Rita Emma, Daniele Balasus, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma. Advances in Biological Regulation 2017; 65: 59 doi: 10.1016/j.jbior.2017.06.002
|
| 16 |
H.‐Y. Xie, C.‐Y. Xing, B.‐J. Wei, X. Xu, J. Wu, L.‐M. Chen, G.‐Q. Cao, H. Chen, K.‐J. Chen, S.‐Y. Yin, L.‐M. Wu, L. Zhou, S.‐S. Zheng. Association of IGF1R polymorphisms with the development of HBV‐related hepatocellular carcinoma. Tissue Antigens 2014; 84(3): 264 doi: 10.1111/tan.12360
|